Genetic risk factors for dilated cardiomyopathy

QR Code

Genetic risk factors for dilated cardiomyopathy

Aim. To study the diagnostic significance of genetic testing in patients with dilated cardiomyopathy (DCM), identify predictors of life-threatening ventricular tachyarrhythmias (VTAs) and assess adverse clinical outcomes in different genetic groups.Material and methods. The study included 126 unrela...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. G. Vaikhanskaya, L. N. Sivitskaya, O. D. Levdansky, T. V. Kurushko, N. G. Danilenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-11-01
Series:	Российский кардиологический журнал
Subjects:	sudden cardiac death genetic screening dilated cardiomyopathy lamin a/c gene (lmna) titin gene (ttn) risk predictors
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4628
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic spectrum of familial and sporadic dilated cardiomyopathy: arrhythmic phenotypes associated with mutations in the lamin A/C (LMNA) gene
by: T. G. Vaikhanskaya, et al.
Published: (2023-05-01)

Dilated cardiomyopathy: reconceptualization of the problem
by: T. G. Vaykhanskaya, et al.
Published: (2019-05-01)

AN INDIVIDUALIZED RISK ASSESSMENT OF SUDDEN CARDIAC DEATH IN DILATION CARDIOMYOPATHY PATIENTS
by: T. G. Vaykhanskaya, et al.
Published: (2016-11-01)

LAMIN A/C GENE (LMNA) MUTATIONS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND THEIR PHENOTYPIC MANIFESTATION
by: T. G. Vaikhanskaya, et al.
Published: (2016-03-01)

Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy
by: A. M. Kiselev, et al.
Published: (2019-11-01)

Arrhythmogenic Cardiomyopathy in 8-Year-Old Girl: Clinical Case. Difficult Path to Diagnosis
by: Olga A. Kofeynikova, et al.
Published: (2023-12-01)

AN ORPHAN PHENOTYPE OF CARDIOGENITAL LAMINOPATHY — MALOUF SYNDROME
by: T. G. Vaykhanskaya, et al.
Published: (2016-11-01)

Non-compaction cardiomyopathy. Part II: limitations of imaging techniques and genetic screening, clinical observations
by: T. G. Vaikhanskaya, et al.
Published: (2020-12-01)

Non-compaction and dilated cardiomyopathy: genotypic, phenotypic and prognostic differences
by: T. G. Vaykhanskaya, et al.
Published: (2022-11-01)

Sudden cardiac death risk stratification in dilated cardiomyopathy: a state of the art review
by: B. Sh. Berdibekov, et al.
Published: (2025-05-01)

Non-compaction cardiomyopathy. Part I: clinical and genetic heterogeneity and predictors of unfavorable prognosis
by: T. G. Vaikhanskaya, et al.
Published: (2020-12-01)

EFFICACY OF CARDIOVERTER-DEFIBRILLATORS IN PREVENTION OF SUDDEN DEATH AND OVERALL MORTALITY DECREASE IN PATIENTS WITH THE SYNDROME OF DILATION CARDIOMYOPATHY: DIFFERENTIAL APPROACH
by: O. V. Blagova, et al.
Published: (2018-03-01)

Atrial fibrillation in patients with dilated cardiomyopathy: prevalence, risk factors and prognostic significance
by: T. G. Vaikhanskaya, et al.
Published: (2023-11-01)

Cardiac Phenotype Associated with Two Heterozygous <i>LMNA</i> Variants
by: Aura Siikjärvi, et al.
Published: (2025-05-01)

Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits
by: Lorenzo‐Lupo Dei, et al.
Published: (2025-06-01)

SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01)

Advances in animal models and treatment of dilated cardiomyopathy
by: JIN Jiamin, et al.
Published: (2024-02-01)

The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities
by: E. A. Mershina, et al.
Published: (2015-12-01)

<i>MYBPC3</i>-associated cardiomyopathy: features of the course and prospects for specific therapy
by: D. A. Nefedova, et al.
Published: (2025-02-01)

CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01)

Discovering new hub genes of dilated cardiomyopathy
by: Jun‐Yan Zhu, et al.
Published: (2025-08-01)

Restrictive cardiomyopathy: difficulties desminopathy diagnostics
by: T. G. Vaikhanskaya, et al.
Published: (2019-11-01)

Functional geometry of the left ventricle in dilated cardiomyopathy before and after resynchronization therapy
by: T. V. Chumarnaya, et al.
Published: (2016-02-01)

Pathogenic Variant Rs1471414348of the TTN Gene in the Patient with Familial Left Venticular Noncompaction Cardiomyopathy
by: O. V. Kulikova, et al.
Published: (2019-09-01)

Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy
by: Fan J, et al.
Published: (2025-07-01)

NON-INVASIVE ELECTROPHYSIOLOGICAL MARKERS OF HIGHER RISK FOR FATAL OUTCOMES IN DILATION CARDIOMYOPATHY PATIENTS
by: A. V. Sedov, et al.
Published: (2017-02-01)

LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
by: E. V. Resnik, et al.
Published: (2024-10-01)

Prognosis of Pediatric Dilated Cardiomyopathy: Nomogram and Risk Score Models for Predicting Death/Heart Transplantation
by: Bowen Xu, et al.
Published: (2025-07-01)

Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 10 (LGMD,10), Caused by a Novel Homozygous Variant in the TTN Gene
by: Alghamdi OA, et al.
Published: (2025-06-01)

Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01)

The analysis of sudden cardiac death cases among young persons in the Dnepropetrovsk region
by: Nekhanevich OB, et al.
Published: (2013-01-01)

Association of SCN5A gene polymorphism with dilated cardiomyopathy
by: S. Yu. Nikulina, et al.
Published: (2021-09-01)

Deceleration and acceleration capacities of heart rate in patients with hypertrophic cardiomyopathy: results of a five-year prospective study
by: D. A. Tsaregorodtsev, et al.
Published: (2022-08-01)

“Muscle Bridge” as a Possible Risk Factor for Sudden Cardiac Death in a Child with Hypertrophic Cardiomyopathy: Case Study
by: Larisa A. Balykova, et al.
Published: (2025-07-01)

Platelet aggregation activity and beta-adrenoblocker therapy in patients with dilated cardiomyopathy
by: P. N. Isakhanova, et al.
Published: (2012-02-01)

Electrocardiographic parameters and features of ventricular arrhythmias in various arrhythmogenic cardiomyopathy forms in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-09-01)

Carvajal syndrome: a brief overview and clinical case of cardiomyopathy, associated with compound heterozygous mutations of the desmoplakin gene
by: T. G. Vaikhanskaya, et al.
Published: (2018-11-01)

Biventricular hypertrophic cardiomyopathy with ACTC1 and LDB3 mutations, results of primary prevention of sudden cardiac death: а case report
by: V. N. Larina, et al.
Published: (2025-05-01)

Contribution of electrocardiography to the diagnosis of cardiomyopathies and athletic heart syndrome
by: O. S. Chumakova, et al.
Published: (2020-09-01)

Abnormal Pre-Participation Cardiac Screening in Athletes
by: Raghav T. Bhatia, MBBS, PhD, et al.
Published: (2025-08-01)